Lucid Diagnostics (LUCD) Total Current Liabilities (2021 - 2025)
Lucid Diagnostics (LUCD) has disclosed Total Current Liabilities for 5 consecutive years, with $26.2 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Total Current Liabilities rose 83.91% year-over-year to $26.2 million, compared with a TTM value of $26.2 million through Sep 2025, up 83.91%, and an annual FY2024 reading of $23.5 million, down 19.94% over the prior year.
- Total Current Liabilities was $26.2 million for Q3 2025 at Lucid Diagnostics, down from $29.4 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $36.6 million in Q1 2025 and bottomed at $4.3 million in Q4 2021.
- Average Total Current Liabilities over 5 years is $20.0 million, with a median of $21.7 million recorded in 2023.
- The sharpest move saw Total Current Liabilities skyrocketed 248.75% in 2023, then crashed 52.86% in 2024.
- Year by year, Total Current Liabilities stood at $4.3 million in 2021, then skyrocketed by 97.77% to $8.4 million in 2022, then surged by 248.75% to $29.4 million in 2023, then decreased by 19.94% to $23.5 million in 2024, then rose by 11.4% to $26.2 million in 2025.
- Business Quant data shows Total Current Liabilities for LUCD at $26.2 million in Q3 2025, $29.4 million in Q2 2025, and $36.6 million in Q1 2025.